Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|May 22, 2010
Diabetes, prediabetes and cardiovascular riskLinda G Mellbin, Matteo Anselmino, Lars Rydén
Diabetes Care|February 24, 2012
Complement activation and prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trialLinda G Mellbin, Mette Bjerre, Steffen Thiel, et al.
BMJ Open|October 28, 2025
Digital cognitive behavioural therapy for cardiac anxiety following acute coronary syndrome: protocol for a randomised controlled trial comparing CBT to a digital lifestyle interventionAmanda Johnsson, Brjánn Ljótsson, Frieder Braunschweig, et al.
European Heart Journal|December 25, 2007
The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trialLinda G Mellbin, Klas Malmberg, Anna Norhammar, et al.
European Heart Journal|November 13, 2012
The relationship between glycaemic variability and cardiovascular complications in patients with acute myocardial infarction and type 2 diabetes: a report from the DIGAMI 2 trialLinda G Mellbin, Klas Malmberg, Lars Rydén, et al.
Diabetes & Vascular Disease Research|January 26, 2017
Copeptin in patients with acute myocardial infarction and newly detected glucose abnormalities - A marker of increased stress susceptibility? A report from the Glucose in Acute Myocardial Infarction cohortMaria Isabel Smaradottir, Viveca Ritsinger, Viveca Gyberg, et al.
Diabetes Care|April 24, 2010
Copeptin, IGFBP-1, and cardiovascular prognosis in patients with type 2 diabetes and acute myocardial infarction: a report from the DIGAMI 2 trialLinda G Mellbin, Lars Rydén, Kerstin Brismar, et al.
Diabetes & Vascular Disease Research|October 4, 2018
Dynamics of testosterone levels in patients with newly detected glucose abnormalities and acute myocardial infarctionAnne Wang, Stefan Arver, John Flanagan, et al.
Diabetes & Vascular Disease Research|October 13, 2018
Copeptin and insulin-like growth factor binding protein-1 during follow-up after an acute myocardial infarction in patients with type 2 diabetes: A report from the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction 2 cohortMaria Isabel Smáradóttir, Sergiu-Bogdan Catrina, Kerstin Brismar, et al.
European Heart Journal Open|August 5, 2022
Androgen receptor polymorphism, testosterone levels, and prognosis in patients with acute myocardial infarctionAnne Wang, John Flanagan, Stefan Arver, et al.
Pageof 3